🚨 Breaking News!
NMPA grants conditional approval for #Olgotrelvir Sodium Capsules by ACEA Pharma!
💊 Oral antiviral for mild–moderate COVID-19

📧 info@dengyuemed.com

#OlgotrelvirSodium #ACEAPharmaceutical #COVID19 #OralAntiviral #InnovativeMedicine #VirusInfection
#HongKongDengYueMedicine

How To Measure Benefit in a Changing Pandemic — Olgotrelvir for SARS-CoV-2 Since January 2020, there have been over 775 million confirmed cases of Covid-19 and 7 million deaths globally.1 Vaccinations and increased virologic exposure in the population have attenuated the ...

#MedSky🧪 #IDSky #Immunosky #pharmsky #drugdevelopment #publichealth Interesting question to ask How To Measure Benefit in a Changing Pandemic #Olgotrelvir for #SARSCoV2 infection & are we still in the dark ?

evidence.nejm.org/doi/full/10....
@nejm.org

Olgotrelvir, a dual inhibitor of SARS-CoV-2 Mpro and cathepsin L, as a standalone antiviral oral intervention candidate for COVID-19 Mao et al. discovered and developed a next-generation antiviral, olgotrelvir, as a standalone treatment for COVID-19 without ritonavir. Olgotrelvir, with a dual mechanism of action targeting SARS-CoV-...

#Olgotrelvir, a dual inhibitor of #SARSCoV2 #Mpro and cathepsin L, as a standalone antiviral oral intervention candidate for #COVID19
www.cell.com/med/fulltext...
Ref pubmed.ncbi.nlm.nih.gov/38181791/

Olgotrelvir as a Single-Agent Treatment of Nonhospitalized Patients with Covid-19 Olgotrelvir is an oral antiviral with dual mechanisms of action targeting severe acute respiratory syndrome coronavirus 2 main protease (i.e., Mpro) and human cathepsin L. It has potential to serve...

#Olgotrelvir as a Single-Agent Treatment of Nonhospitalized Patients with #COVID19
evidence.nejm.org/doi/full/10....

#MedSky🧪 #IDSky #Immunopharmacology #Drugdiscovery Does #olgotrelvir work against #SARSCoV2? Taken together, these data suggest yes — given evidence for both symptomatic and virologic improvement in an overall low-risk, young population.

Olgotrelvir as a Single-Agent Treatment of Nonhospitalized Patients with Covid-19 Olgotrelvir is an oral antiviral with dual mechanisms of action targeting severe acute respiratory syndrome coronavirus 2 main protease (i.e., Mpro) and human cathepsin L. It has potential to serve...

#MedSky🧪 #IDSky
Does #olgotrelvir ( an oral #antiviral with dual mechanisms of action targeting severe #COVID main protease (i.e. #Mpro) & human #cathepsin L. It has potential to serve as a single-agent treatment For #COVID19
evidence.nejm.org/doi/full/10.... ) work against #SARSCoV2 ?